ARTICLE | Clinical News
Avidimer preclinical data
June 27, 2005 7:00 AM UTC
In a mouse model of epithelial cancer, the nanoparticle-based dendrimer therapy had a 30-40% survival rate compared to 0% with mice given methotrexate. There also was a statistically significant tumor...